SmartestCrowd
Organizations
Orgs
No organizations
Projects
No projects
0
0
Dual LAMA/LABA or triple therapy may raise CV risk among COPD patients - Medical Dialogues
10/17/22 at 7:00am
Organization
Medical Dialogues
Author
Dr. Kamal Kant Kohli
30 words
0
Comments
CHINA: According to a research reported in The European Respiratory Journal, dual LAMA/LABA or...
Health
Respiratory Conditions
LAMA
LABA
China
COPD
LABA
The European Respiratory Journal
You are the first to view
https://medicaldialogues.in/pulmonology/news/dual-lamalaba-or-triple-therapy-may-raise-cv-risk-among-copd-patients-100530
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...